Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Auto-FMT for Gut Microbiome Restoration After Antibiotics
NCT06250413Not yet recruiting
- Start
- Feb 2024
- Primary completion
- Dec 2026
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Randomised, double-blind trial of fecal microbiome transplant (2 arms). Primary endpoints: Feasibility and safety; Number of participants with treatment-related adverse events at 2 months and Taxonomic restoration of the gut microbiome at Day 27. Planned start Feb 2024; status: not yet recruiting.
02
Drugs
fecal microbiome transplant
Beyond the preview
Go deeper on NCT06250413.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06250413.